Mesoblast Limited (MESO)
Mesoblast Statistics
Share Statistics
Mesoblast has 126.9M shares outstanding. The number of shares has increased by 39.35% in one year.
| Shares Outstanding | 126.9M |
| Shares Change (YoY) | 39.35% |
| Shares Change (QoQ) | 5.44% |
| Owned by Institutions (%) | 0.32% |
| Shares Floating | 652.04M |
| Failed to Deliver (FTD) Shares | 4.95K |
| FTD / Avg. Volume | 1.32% |
Short Selling Information
The latest short interest is 1.86M, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 1.86M |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 2.25 |
Valuation Ratios
The PE ratio is -7.48 and the forward PE ratio is -33.31. Mesoblast's PEG ratio is 0.39.
| PE Ratio | -7.48 |
| Forward PE | -33.31 |
| PS Ratio | 111.47 |
| Forward PS | 2.3 |
| PB Ratio | 1.37 |
| P/FCF Ratio | -13.48 |
| PEG Ratio | 0.39 |
Enterprise Valuation
Mesoblast Limited has an Enterprise Value (EV) of 655.11M.
| EV / Earnings | -7.45 |
| EV / Sales | 111 |
| EV / EBITDA | -11.68 |
| EV / EBIT | -7.79 |
| EV / FCF | -13.43 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.18 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.25 |
| Total Debt / Capitalization | 19.84 |
| Cash Flow / Debt | -0.41 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.18% and return on capital (ROIC) is -14.07%.
| Return on Equity (ROE) | -0.18% |
| Return on Assets (ROA) | -0.13% |
| Return on Capital (ROIC) | -14.07% |
| Revenue Per Employee | $80,849.32 |
| Profits Per Employee | $-1,204,876.71 |
| Employee Count | 73 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 191K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 165.27% in the last 52 weeks. The beta is 2.13, so Mesoblast's price volatility has been higher than the market average.
| Beta | 2.13 |
| 52-Week Price Change | 165.27% |
| 50-Day Moving Average | 16.38 |
| 200-Day Moving Average | 11.04 |
| Relative Strength Index (RSI) | 37.46 |
| Average Volume (20 Days) | 373.83K |
Income Statement
In the last 12 months, Mesoblast had revenue of 5.9M and earned -87.96M in profits. Earnings per share was -0.09.
| Revenue | 5.9M |
| Gross Profit | -35.17M |
| Operating Income | -84.15M |
| Net Income | -87.96M |
| EBITDA | -56.08M |
| EBIT | -84.15M |
| Earnings Per Share (EPS) | -0.09 |
Balance Sheet
The company has 62.56M in cash and 118.92M in debt, giving a net cash position of -56.36M.
| Cash & Cash Equivalents | 62.56M |
| Total Debt | 118.92M |
| Net Cash | -56.36M |
| Retained Earnings | -908.76M |
| Total Assets | 653.32M |
| Working Capital | -3.07M |
Cash Flow
In the last 12 months, operating cash flow was -48.46M and capital expenditures -331K, giving a free cash flow of -48.79M.
| Operating Cash Flow | -48.46M |
| Capital Expenditures | -331K |
| Free Cash Flow | -48.79M |
| FCF Per Share | -0.05 |
Margins
Gross margin is -595.87%, with operating and profit margins of -1.43K% and -1.49K%.
| Gross Margin | -595.87% |
| Operating Margin | -1.43K% |
| Pretax Margin | -1.49K% |
| Profit Margin | -1.49K% |
| EBITDA Margin | -950.14% |
| EBIT Margin | -1.43K% |
| FCF Margin | -826.65% |
Dividends & Yields
MESO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.68% |
| FCF Yield | -2.89% |
Analyst Forecast
The average price target for MESO is $18, which is 35.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $18 |
| Price Target Difference | 35.4% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jan 10, 2024. It was a backward split with a ratio of 1:2.
| Last Split Date | Jan 10, 2024 |
| Split Type | backward |
| Split Ratio | 1:2 |
Scores
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 3 |